Pediatric patients with T1DM, regarding their higher future risk of CVD, are characterized by higher concentrations of protective adiponectin and paradoxically lower blood concentrations of some other possible markers of atherosclerosis, comparatively with healthy children [44]. This evidence concerns the gene ADIPOQ and atherosclerosis.